Training and Continuing Education
An Introduction to the Improved FDA Prescription Drug Labeling
| About This Site: The FDA has contracted development and management of this educational activity. FDA’s privacy policy applies while you are on this site. Accreditation for this course expired November 23, 2010. If you happen to find this site elsewhere on the web, keep in mind that continuing education credits will no longer be awarded. |
- Activity Description, Learning Objectives, and General Instructions
- Disclosure
- Speaker Biographies
- Activity Time
- Replacement of CE Statement of Credit/Certificate of Completion (non-CE)
- Privacy Policy
- Download Presentation Transcript
- Download Slides (PDF - 1.8MB)
- Updated Links Within Course
Welcome to the Food and Drug Administration, Center for Drug Evaluation and Research's educational activity entitled, "An Introduction to the Improved FDA Prescription Drug Labeling." This activity is designed to give you a better understanding of the revised prescription drug labeling, the format changes that were made, and why they were necessary. You will also learn about other labeling initiatives that have brought the FDA into the 21st century of promoting and protecting the health of the American people. The goal of this activity is to make information about the revised labeling clearer and more easily understood. Upon completion of this activity, the participant will be able to:
General Instructions (Plugins, Audio) Plugins - If you do not currently have the Adobe Flash Player and/or the Adobe Reader installed on your computer, you can click the appropriate link to launch the download page in a new window.
Audio - Before entering the activity, turn on your computer's speakers. |







